Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Increased serum HMGB1 related with HbA1c in coronary artery disease with type 2 diabetes mellitus.

Zhao D, Wang Y, Tang K, Xu Y.

Int J Cardiol. 2013 Sep 30;168(2):1559-60. doi: 10.1016/j.ijcard.2012.12.073. Epub 2013 Jan 19. No abstract available.

PMID:
23336955
2.

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.

Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, Zhang RY, Chen QJ, Shen WF.

Atherosclerosis. 2009 Aug;205(2):544-8. doi: 10.1016/j.atherosclerosis.2008.12.016. Epub 2008 Dec 14.

PMID:
19150066
3.

Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease.

Farhan S, Jarai R, Tentzeris I, Kautzky-Willer A, Samaha E, Smetana P, Jakl-Kotauschek G, Wojta J, Huber K.

Clin Res Cardiol. 2012 Aug;101(8):625-30. doi: 10.1007/s00392-012-0435-3. Epub 2012 Mar 6.

PMID:
22391987
4.

Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.

Lu L, Pu LJ, Xu XW, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Lu AK, Ding FH, Shen J, Chen QJ, Lou S, Fang DH, Shen WF.

Clin Biochem. 2007 Jul;40(11):810-6. Epub 2007 Apr 19.

PMID:
17499233
5.

Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk.

Peter A, Fritsche A, Stefan N, Heni M, Häring HU, Schleicher E.

Exp Clin Endocrinol Diabetes. 2011 Apr;119(4):234-7. doi: 10.1055/s-0030-1270440. Epub 2011 Jan 24.

PMID:
21264802
6.

Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery.

Alserius T, Anderson RE, Hammar N, Nordqvist T, Ivert T.

Scand Cardiovasc J. 2008 Dec;42(6):392-8. doi: 10.1080/14017430801942393.

PMID:
18609043
7.

Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.

Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY, Shen WF.

Can J Cardiol. 2012 Nov-Dec;28(6):737-43. doi: 10.1016/j.cjca.2012.08.015. Epub 2012 Oct 13.

PMID:
23073352
8.

Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.

Kataoka Y, Shao M, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ.

Eur J Prev Cardiol. 2013 Apr;20(2):209-17. doi: 10.1177/2047487312437931. Epub 2012 Jan 31.

PMID:
22345692
9.

Is haemoglobin A1c a step forward for diagnosing diabetes?

Kilpatrick ES, Bloomgarden ZT, Zimmet PZ.

BMJ. 2009 Nov 10;339:b4432. doi: 10.1136/bmj.b4432. No abstract available.

PMID:
19903702
10.

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.

Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K, Maeda H, Fujisue K, Yamamoto E, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H.

Circ J. 2013;77(5):1337-44. Epub 2013 Feb 2.

11.
12.

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.

Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, Yoshimura M, Ogawa H, Fujioka D, Kugiyama K.

J Am Coll Cardiol. 2004 Jun 16;43(12):2219-24.

13.

Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008.

Fhärm E, Cederholm J, Eliasson B, Gudbjörnsdottir S, Rolandsson O.

Diabet Med. 2012 Feb;29(2):198-206. doi: 10.1111/j.1464-5491.2011.03425.x.

PMID:
21883434
15.

Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients.

Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY, Shen WF.

Cardiology. 2012;123(2):84-90. doi: 10.1159/000342055. Epub 2012 Sep 25.

PMID:
23018602
16.

Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus.

Yamashita A, Nishihira K, Matsuura Y, Ito T, Kawahara K, Hatakeyama K, Hashiguchi T, Maruyama I, Yagi H, Matsumoto M, Fujimura Y, Kitamura K, Shibata Y, Asada Y.

Atherosclerosis. 2012 Oct;224(2):511-4. doi: 10.1016/j.atherosclerosis.2012.07.027. Epub 2012 Jul 25.

PMID:
22862965
17.

Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus.

Ueda H, Mitsusada N, Harimoto K, Miyawaki M, Yasuga Y, Hiraoka H.

Cardiology. 2010;116(1):51-7. doi: 10.1159/000314331. Epub 2010 May 10.

PMID:
20453503
18.

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbjörnsdóttir S, Eliasson B.

J Intern Med. 2010 Nov;268(5):471-82. doi: 10.1111/j.1365-2796.2010.02265.x.

19.

Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus.

Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Weiss MB.

Am J Cardiol. 2006 Apr 1;97(7):968-9. Epub 2006 Feb 13.

PMID:
16563896

Supplemental Content

Support Center